These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20854180)

  • 1. Targeting Fas in osteoresorptive disorders.
    Kovacic N; Grcevic D; Katavic V; Lukic IK; Marusic A
    Expert Opin Ther Targets; 2010 Oct; 14(10):1121-34. PubMed ID: 20854180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas receptor is required for estrogen deficiency-induced bone loss in mice.
    Kovacic N; Grcevic D; Katavic V; Lukic IK; Grubisic V; Mihovilovic K; Cvija H; Croucher PI; Marusic A
    Lab Invest; 2010 Mar; 90(3):402-13. PubMed ID: 20084056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival.
    Krum SA; Miranda-Carboni GA; Hauschka PV; Carroll JS; Lane TF; Freedman LP; Brown M
    EMBO J; 2008 Feb; 27(3):535-45. PubMed ID: 18219273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.
    Hong SE; Lee J; Seo DH; In Lee H; Ri Park D; Lee GR; Jo YJ; Kim N; Kwon M; Shon H; Kyoung Seo E; Kim HS; Young Lee S; Jeong W
    Free Radic Biol Med; 2017 Nov; 112():191-199. PubMed ID: 28774817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis.
    Kovacić N; Lukić IK; Grcević D; Katavić V; Croucher P; Marusić A
    J Immunol; 2007 Mar; 178(6):3379-89. PubMed ID: 17339432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
    Wang L; Liu S; Zhao Y; Liu D; Liu Y; Chen C; Karray S; Shi S; Jin Y
    Cell Death Differ; 2015 Oct; 22(10):1654-64. PubMed ID: 25744024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERα signaling regulates MMP3 expression to induce FasL cleavage and osteoclast apoptosis.
    Garcia AJ; Tom C; Guemes M; Polanco G; Mayorga ME; Wend K; Miranda-Carboni GA; Krum SA
    J Bone Miner Res; 2013 Feb; 28(2):283-90. PubMed ID: 22927007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblast-osteoclast interactions.
    Chen X; Wang Z; Duan N; Zhu G; Schwarz EM; Xie C
    Connect Tissue Res; 2018 Mar; 59(2):99-107. PubMed ID: 28324674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Wnt signals in bone resorption during physiological and pathological states.
    Maeda K; Takahashi N; Kobayashi Y
    J Mol Med (Berl); 2013 Jan; 91(1):15-23. PubMed ID: 23111637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.
    Kohara H; Kitaura H; Fujimura Y; Yoshimatsu M; Morita Y; Eguchi T; Masuyama R; Yoshida N
    Immunol Lett; 2011 Jun; 137(1-2):53-61. PubMed ID: 21338623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.
    Yang Y; Blair HC; Shapiro IM; Wang B
    J Biol Chem; 2015 Jul; 290(27):16918-28. PubMed ID: 25979341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone.
    Sims SM; Panupinthu N; Lapierre DM; Pereverzev A; Dixon SJ
    Biochim Biophys Acta; 2013 Jan; 1831(1):109-16. PubMed ID: 22892679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
    Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
    Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
    Baum R; Gravallese EM
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling.
    Muguruma Y; Hozumi K; Warita H; Yahata T; Uno T; Ito M; Ando K
    J Cell Physiol; 2017 Sep; 232(9):2569-2580. PubMed ID: 27735989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of osteoblastic Arl6ip5 impaired osteoblast differentiation and enhanced osteoclastogenesis via disturbance of ER calcium homeostasis and induction of ER stress-mediated apoptosis.
    Wu Y; Yang M; Fan J; Peng Y; Deng L; Ding Y; Yang R; Zhou J; Miao D; Fu Q
    Cell Death Dis; 2014 Oct; 5(10):e1464. PubMed ID: 25321471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.
    Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH
    J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.
    Mukherjee A; Rotwein P
    Mol Cell Biol; 2012 Jan; 32(2):490-500. PubMed ID: 22064480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-β in the bone microenvironment.
    Yang T; Grafe I; Bae Y; Chen S; Chen Y; Bertin TK; Jiang MM; Ambrose CG; Lee B
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7336-41. PubMed ID: 23589896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.